» Authors » M E Velthuizen

M E Velthuizen

Explore the profile of M E Velthuizen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 65
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bokkers K, Bleiker E, Velthuizen M, Koelemij R, Burgmans J, Klinkenbijl J, et al.
Breast . 2023 Apr; 69:349-357. PMID: 37018966
Background: Pre-test genetic counseling of patients with breast cancer is increasingly being offered by non-genetic healthcare professionals. We aimed to evaluate the experiences of patients with breast cancer receiving pre-test...
2.
Bokkers K, Bleiker E, Aalfs C, van Dalen T, Velthuizen M, Duijveman P, et al.
Ann Surg Oncol . 2023 Feb; 30(6):3248-3258. PMID: 36853565
Background: Pre-test genetic counseling for patients with breast cancer is increasingly being provided by nongenetic healthcare professionals. We evaluated the attitudes, knowledge, and self-efficacy of surgeons, oncologists, and nurses regarding...
3.
Bokkers K, Frederix G, Velthuizen M, van der Aa M, Gerestein C, Van Dorst E, et al.
Gynecol Oncol . 2022 Aug; 167(1):115-122. PMID: 36031452
Objective: Germline genetic testing is increasingly offered to patients with epithelial ovarian cancer by non-genetic healthcare professionals, so called mainstream genetic testing. The aim of this study was to evaluate...
4.
Bakhuizen J, Hogervorst F, Velthuizen M, Ruijs M, van Engelen K, van Os T, et al.
Fam Cancer . 2019 Jan; 18(2):273-280. PMID: 30607672
Early-onset breast cancer may be due to Li-Fraumeni Syndrome (LFS). Current national and international guidelines recommend that TP53 genetic testing should be considered for women with breast cancer diagnosed before...
5.
Bakhuizen J, Velthuizen M, Stehouwer S, Bleiker E, Ausems M
Fam Cancer . 2018 Sep; 18(2):231-239. PMID: 30238178
Germline TP53 mutations are associated with an increased risk of early-onset breast cancer. Traditionally, it was not standard practice to offer TP53 genetic testing due to the low mutation detection...
6.
van der Giessen J, van Riel E, Velthuizen M, van Dulmen A, Ausems M
J Community Genet . 2017 Sep; 8(4):303-310. PMID: 28868568
Participation rates in cancer genetic counseling differ among populations, as patients with a lower educational background and migrant patients seem to have poorer access to it. We conducted a study...
7.
Baars J, van Dulmen A, Velthuizen M, van Riel E, Ausems M
J Community Genet . 2017 Jan; 8(2):97-108. PMID: 28083845
Lower participation rates in cancer genetic counseling are observed among different ethnic minorities. The goal of our study is to gain insight into determinants of Turkish and Moroccan patients' participation...
8.
Baars J, van Dulmen A, Velthuizen M, Theunissen E, Vrouenraets B, Kimmings A, et al.
Fam Cancer . 2016 Feb; 15(2):163-71. PMID: 26833044
Certain ethnic groups seem to have less access to cancer genetic counseling. Our study was to investigate the participation in cancer genetic counseling among migrant breast cancer patients of Turkish...
9.
Eijzenga W, Bleiker E, Ausems M, Sidharta G, van der Kolk L, Velthuizen M, et al.
Clin Genet . 2014 Aug; 87(5):419-27. PMID: 25130962
Approximately 70% of counselees undergoing cancer genetic counseling and testing (CGCT) experience some degree of CGCT-related psychosocial problems. We evaluated the efficacy of an intervention designed to increase detection and...
10.
Baars J, Bleiker E, van Riel E, Rodenhuis C, Velthuizen M, Schlich K, et al.
Clin Genet . 2013 Dec; 85(6):524-31. PMID: 24372530
Genetic counseling and DNA testing (GCT) for breast cancer is increasingly being actively offered to newly diagnosed patients. Little is known about the consequences of such an approach. Therefore, the...